GE HealthCare Technologies Inc
GEHC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$38.79B
Close$
Earnings Call Q3 2026
October 28, 2026 - AI Summary
Q3 performance: strong growth + margin expansion; guidance raised
- Revenue $5.5B, +6.2% organic (reported product +6.7%, service +8.1%).
- Organic orders +4%, book-to-bill 1.03x; backlog $23.7B (+12% YoY).
- Adjusted EBIT margin 16.6% (+180 bps YoY); adjusted EPS $1.34 (+25.1% YoY).
- Free cash flow $793M (+$310M YoY).
- FY2026 guidance raised: organic revenue ~4%, adjusted EBIT margin 15.5%–15.7%, adjusted EPS $4.95–$5.05, free cash flow > $1.6B, FX tailwind ~75 bps, effective tax rate 20%–21%.
Demand / pipeline momentum: “heartbeat” execution driving consistency
- Management cited broad-based demand in advanced imaging and pharmaceutical diagnostics supporting orders and backlog.
- Heartbeat (standard work + daily management) used to fix operational issues and improve reliability; concrete example: Patient Care Solutions improved fulfillment/monitoring and backlog conversion after prior supply challenges.
- Management said capex environment looks constructive based on customer survey inputs and a strong funnel; any procedure volatility is not yet showing up directly in scan/contrast usage data and would take multiple quarters to appear in equipment demand.
Segment drivers (what’s working)
- Advanced Imaging Solutions: organic revenue +4.5% (CT, cardiovascular/interventional, surgical innovations); EBIT margin +130 bps (volume, lower tariffs, price; partially offset by inflation).
- Pharmaceutical Diagnostics (PDX): organic revenue +13.8% (contrast media + radiopharma); EBIT margin to 29.9% (+50 bps) (volume/price; planned investments for new products).
- Patient Care Solutions (PCS): organic revenue +8.8% YoY with a very large EBIT margin expansion (+480 bps YoY); sequential improvement attributed to improved supplier/factory execution and daily cadence.
- Notable Q4 headwind/comp referenced: Q4’25 had ~ $45M revenue from a product hold release, which will affect year-over-year comparisons.
Exclusive for Stockcircle Pro members
Sign up
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $38.79 Billion |
|---|---|
| Enterprise Value | $48.97 Billion |
| Annual dividend | $0.14 |
| Dividend yield | 0.19% |
| Earnings per Share | $4.56 |
| Beta | 0.85 |
| Outstanding Shares | 452,000,000 |
Return
| Return on Equity | 16.04% |
|---|---|
| Return on Assets | 4.73% |
| Return on Invested Capital | 8.73% |
Valuation & Multiples
| P/E Ratio | 19.84 |
|---|---|
| PEG | 52.66 |
| Price to Sales | 1.91 |
| Price to Book Ratio | 3.58 |
| Enterprise Value to Revenue | 2.38 |
| Enterprise Value to EBIT | 19.37 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 1.12 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS Estimate
$1.21
Consensus analyst estimateRevenue Estimate
$5.35 B
Consensus analyst estimateNext Earnings Call
Expected Date
February 3, 2027
EPS Estimate
$1.55
Consensus analyst estimateRevenue Estimate
$5.92 B
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 54.52% |
|---|---|
| Total Calls | 83▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.78%▼ 83.96% |
|---|---|
| Total Invested | $1.12B▼ 95.61% |
| Investors Holding | 457▼ 814.00% |